New treatment options for advanced pancreatic cancer. - Wikidata - wikimedia - TriplyDB

New treatment options for advanced pancreatic cancer.

New treatment options for advanced pancreatic cancer.

http://www.wikidata.org/entity/Q37345841

about

Allogeneic tumor cell vaccines: the promise and limitations in clinical trials Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades.New biomarkers and targets in pancreatic cancer and their application to treatment.Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways.Protective effects of GV1001 on myocardial ischemia‑reperfusion injury.

P2860

Q26852333-8EADA754-7CC2-40C4-934B-86EE89045836 Q33566269-DA6C9620-A530-4E86-8A00-7638276E9977 Q33684453-F6F02E56-B8A0-4680-A296-C6ED47920035 Q33857806-820204E6-7EAD-4C6C-A00F-0EB1BB83084D Q34363535-CB916DB9-C297-43D8-82FC-38388630E45C Q36299358-3CED5C44-920E-421A-A767-711FACBCA2D6 Q38021692-A37415B4-347E-4C37-8812-A7142889523A Q38899542-08AA4014-D3BB-4272-AAB9-4E8F772BA718 Q39836928-134D100D-BE3E-4890-AE7B-410B7E1C7CD7 Q49852588-58F31D0E-39EA-4D3C-9F94-5287748BCBB5

P2860

New treatment options for advanced pancreatic cancer.

http://www.wikidata.org/entity/Q37345841

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New treatment options for advanced pancreatic cancer.

@en

New treatment options for advanced pancreatic cancer.

@nl

type

label

New treatment options for advanced pancreatic cancer.

@en

New treatment options for advanced pancreatic cancer.

@nl

prefLabel

New treatment options for advanced pancreatic cancer.

@en

New treatment options for advanced pancreatic cancer.

@nl

P1433

Q37345841-3762E7BC-01B2-4B85-B639-1A42AB2C9CBE

P1476

Q37345841-61266EE5-17F6-46CF-B21D-40E88AB75713

P2093

Q37345841-197FB56C-A884-4FF8-8453-F1503FAA2C19

Q37345841-7DF0F717-207A-4E76-8A47-2D820E770AA5

Q37345841-859280CB-48F7-4D7F-B6B3-CEA59FE90533

P2860

Q37345841-0159865F-8D63-46AB-97BE-FFAB05F00755

Q37345841-054CBC22-438C-444B-A2C7-245B179E9CA1

Q37345841-0591C1C8-2973-431E-8DE2-C90137A5DAC0

Q37345841-08B84E6F-C815-493E-AE7B-D54A55340186

Q37345841-0BCF536D-E6AC-4D3D-B018-E2FD06272192

Q37345841-0E25A8FD-DFD1-441C-98AE-714DEC5A1D67

Q37345841-0FED345C-69FC-4271-9DCB-A96F0121DD1E

Q37345841-108329DF-47E6-41F5-BB5A-8C352EDFA8C5

Q37345841-1375A87B-B8DE-470A-92D4-CA8578AC4F06

Q37345841-1C5CC2A8-EE52-47CA-9C3B-70B4E6172921

P304

Q37345841-ED764A0C-F226-47A5-BABA-643B2D8EFB1F

P31

Q37345841-91839214-4E34-4F9C-9721-150129B789F5

P356

Q37345841-CFDEC6CB-C5BB-4F7C-8F8F-A59439AD36A3

P433

Q37345841-9D00B0A0-A550-4C8D-90C7-097AC2E93DB6

P478

Q37345841-B6CB18D2-60C0-4514-83EE-D3DED1AD29C5

P50

Q37345841-222261DB-CA5F-429D-978A-9808C27A3BE1

Q37345841-55BBCD6D-7CF9-4A6B-BBC6-3797A2C4CFD4

P577

Q37345841-99A79624-FD25-41DB-A678-2F068FB5233E

P698

Q37345841-E7E2036D-439C-4335-A834-F8A8D6254FE4

P356

17474124.2.5.673

P1433

Expert Review of Gastroenterology & Hepatology

P1476

New treatment options for advanced pancreatic cancer.

@en

P2093

Gary Middleton

http://www.w3.org/2001/XMLSchema#string

Paula Ghaneh

http://www.w3.org/2001/XMLSchema#string

William Greenhalf

http://www.w3.org/2001/XMLSchema#string

P2860

Nuclear factor-kB, an unappreciated tumor suppressor

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Effects of STI571 (gleevec) on pancreatic cancer cell growth

Cancer statistics, 2008

Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior

Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Effect of Flt3 ligand gene transfer in experimental pancreatic cancer

P304

673-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2.5.673

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

John P Neoptolemos

Eithne Costello

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19072345

http://www.w3.org/2001/XMLSchema#string